Company Directory / research
PrivateFor profitresearchSingapore, Singapore
Tessa Therapeutics
Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors.
- Founded
- 2001 25 years ago
- Staff
- 101-250 band, as listed
- Followers
- - on LinkedIn
- Funding
- $256M as listed, currency not stated
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed
Age
25 years old.
Reach
Website ranked #8,450,300 in the world for traffic, about 531 visits a month.
What it does
BiotechnologyHealth CareTherapeutics
Funding, as listed
$256M currency not stated
- Rounds5
- LatestGrant, May 2023
- Investors8, 3 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Tessa Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Tessa Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2001
- Founders
- Andrew Khoo, Malcolm Brenner
- Industry
- research
- Categories
- Biotechnology, Health Care, Therapeutics
Where
- City
- Singapore
- Country
- Singapore
- Markets
- Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia
Size and reach
- Staff band
- 101-250
- Web traffic rank
- #8,450,300
- Monthly web visits
- 531
Funding, as listed
- Total
- 256,074,383 (currency not stated)
- Rounds
- 5
- Latest round
- Grant
- Latest round date
- May 2023
- Investors
- 8
- Lead investors
- 3
- Listing status
- private
Corporate family
- Acquisitions made
- 1
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Tessa Therapeutics may be growing as it operates within the cell therapy market, which is projected to grow at a CAGR of 22.67% until 2033, indicating a favorable industry trend that could benefit the company. Although the news articles do not provide direct financial data for Tessa Therapeutics, the company's alignment with a rapidly expanding market suggests potential for growth. Furthermore, being in the biotechnology, health care, and therapeutics industries, Tessa Therapeutics could be among the companies to watch, as highlighted in an article discussing biotech companies in 2023, which may imply industry recognition and potential for expansion.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Singapore.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 17,167 companies in Singapore and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.